MENU
SONN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Sonnet BioTherapeutics Holdings (SONN) Ownership - Who owns Sonnet BioTherapeutics Holdings?
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company... Show more
Profile
Industry
N/A
Address
100 Overlook Center
Phone
+1 609 375-2227
Employees
12
Web
https://www.sonnetbio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
3.64M
P/E Ratio
0.29
Total Cash
2.06M
Projected Growth
N/A
Total Debt
90.45K
Revenue
1M
Risk (Beta)
1.23
Dividend Yield
N/A
Total Cash/Share
0.65
Total Debt/Equity
N/A
Revenue/Share
0.53 USD as % of share price
Fundamentals
SONN
Capitalization
3.64M
P/E Ratio
0.29
Risk (Beta)
1.23
Dividend Yield
N/A
Total Cash
2.06M
Total Cash/Share
0.65
Total Debt
90.4K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.53%
Revenue
1M
ROE
N/A
Book Value
662K
P/B Ratio
5.50
Cash Flow
N/A
Earnings
-12.07
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
312
Current Ratio
1.03
Current Revenue Per Employee
76923.08
Dividends Per Share - Security
N/A
EBITDA
-13.69M
Float
N/A
Float - Current
N/A
Gross Income Margin
68.36
Revenue To Assets
-272.65
Shares Held By Institutions
259K
Shares Outstanding - Current
3.17M
Total Liabilities
3.17M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-21.233
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a company, which engages in the development of biologic drugs with enhanced single or bispecific mechanisms
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
100 Overlook Center
Phone
+1 609 375-2227
Employees
12
Web
https://www.sonnetbio.com